| APTV |
Report |
Q2 2026 revenue |
BEAT |
pred ~$3.35B vs. cons $3.31B |
MEDIUM |
| APTV |
Report |
Q2 2026 adjusted EBITDA |
BEAT |
pred ~$588M vs. cons $580M |
MEDIUM |
| APTV |
Report |
Q2 2026 adjusted EPS |
BEAT |
pred ~$1.46 vs. cons $1.43 |
MEDIUM |
| APTV |
Guide |
FY2026 revenue |
LOWER |
guide ~$13.00B midpoint vs. cons $13.05B (FY2026) |
MEDIUM |
| APTV |
Guide |
FY2026 adjusted EBITDA |
LOWER |
guide ~$2.42B midpoint vs. cons $2.43B (FY2026) |
MEDIUM |
| APTV |
Guide |
FY2026 adjusted EPS |
LOWER |
guide ~$5.90 midpoint vs. cons $5.95 (FY2026) |
MEDIUM |
| APTV |
Guide |
FY2026 free cash flow |
LOWER |
guide ~$750M midpoint vs. cons $760M (FY2026) |
LOW |
| APTV |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.4% |
— |
MEDIUM |
| APTV |
Return |
5-day cumulative residual |
+0.6% (FADE) |
A modest Q2 adjusted EPS beat of ~$1.46 vs. $1.43 consensus should support the initial reaction, but FY2026 adjusted EPS guidance of ~$5.90 vs. $5.95 consensus leaves the out-period burden largely intact. With Q2 adjusted EBITDA of ~$588M vs. $580M consensus but FY2026 EBITDA guidance near ~$2.42B vs. $2.43B consensus, post-report revisions are likely flat to slightly negative, causing most of the day-1 gain to fade. |
MEDIUM |